Skip to main content
SpringerLink
Log in

Monotherapie met metformine bij diabetes mellitus type 2

Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D. Metformin monotherapy for type 2 diabetes mellitus. The Cochrane Database of Systematic Reviews 2005, Issue 3. CD002966. DOI: 10.1002/14651858.

  • Cochrane-reviews
  • Published:
Huisarts en Wetenschap Aims and scope

Samenvatting

Achtergrond Metformine wordt als bloedglucoseverlagend medicament gebruikt bij de behandeling van patiënten met diabetes type 2. Het verbetert de gevoeligheid voor insuline in lever en perifeer weefsel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  • Dormandy JA, Charbonnel C, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005;366:1279-89.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/huisarts-en-wetenschap-0018-7070.html

       

Authors
  1.    
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

 ,  . Monotherapie met metformine bij diabetes mellitus type 2. HUWE 49, 63–64 (2006). https://doi.org/10.1007/BF03084605

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03084605

Search

Navigation